Enliven Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Enliven Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2020 to Q2 2024.
  • Enliven Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $170K, a 66.3% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $170K -$335K -66.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $256K -$332K -56.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $341K -$329K -49.1% Dec 31, 2023 10-K 2024-03-14
Q3 2023 $423K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $505K +$60K +13.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $588K -$2.55M -81.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $670K -$121K -15.3% Dec 31, 2022 8-K 2023-06-23
Q2 2022 $445K -$484K -52.1% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $3.14M +$2.14M +215% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $791K -$273K -25.7% Dec 31, 2021 10-K 2022-03-15
Q3 2021 $860K -$272K -24% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $929K -$270K -22.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $996K -$269K -21.3% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $1.06M Dec 31, 2020 10-K 2021-03-05
Q3 2020 $1.13M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.2M Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $1.27M Mar 31, 2020 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.